TFF Pharmaceuticals | 8-K: Current report
TFF Pharmaceuticals | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
TFF Pharmaceuticals | 8-K: Current report
TFF Pharmaceuticals | 8-K: Current report
TFF Pharmaceuticals | 424B5: Prospectus
TFF Pharmaceuticals | 8-K: TFF Pharmaceuticals Reports First Quarter Financial Results and Provides Corporate Update
TFF Pharmaceuticals | 10-Q: Quarterly report
TFF Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Mitchell P. Kopin(4.99%),Daniel B. Asher(4.99%), etc.
TFF Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Double Black Diamond Offshore Ltd.(9.12%),Carlson Capital, L.P.(9.12%), etc.
TFF Pharmaceuticals | EFFECT: Others
TFF Pharmaceuticals | 8-K: Current report
TFF Pharmaceuticals | CORRESP: CORRESP
TFF Pharmaceuticals | 424B4: Prospectus
TFF Pharmaceuticals | EFFECT: Others
TFF Pharmaceuticals | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)
TFF Pharmaceuticals | 8-K: Current report
TFF Pharmaceuticals | CORRESP: CORRESP
TFF Pharmaceuticals | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)
TFF Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director KING THOMAS BRAXTON
TFF Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Patane Michael A
No Data